HelloWellness review

HelloWellness shows a $349 charge today for its first three-month sermorelin plan and $349 every 11 weeks afterward. Its NAD⁺ injection product currently shows $297 today and every 11 weeks, with at least three 1,000 mg vials if approved. The homepage still advertises NAD⁺ from $79 a month and says $239 every 11 weeks in a footnote, so the public prices conflict. Its terms identify Southend Pharmacy as a fulfillment partner, but do not establish the dispensing pharmacy for a particular order. Read the limited refund policy before paying.

HelloWellness, operated by HelloWellness, LLC in Texas, is a telehealth platform positioned as a men's longevity brand, selling compounded sermorelin, compounded NAD⁺, glutathione, compounded semaglutide and tirzepatide, and a lipotropic product, plus "longevity protocol" bundles that combine sermorelin, NAD⁺ and a GLP-1. Each plan is presented with an itemized inclusion list: a provider evaluation, the medication if approved, syringes with needles and injection instructions, access to a private community and fast shipping. Every product carries a three-month plan minimum. Its terms name AP Max, Inc. d/b/a Southend Pharmacy as a fulfillment-service partner and allow a patient-chosen pharmacy at the patient's expense; they do not identify the dispensing pharmacy for a particular order.

A subscription flow gated on a provider evaluation, with medication shipped after approval and a private community listed among the inclusions. The public pages do not establish a specific clinical-response channel or time. Itemizing the inclusions per product is a small but genuinely useful habit — you can see that syringes and injection instructions are in the price rather than discovering a supplies charge later, and the NAD⁺ plan states a minimum of three 1,000 mg vials. The published refund terms are specific: if a provider does not approve you, you get a full refund, and if you cancel after a prescription is written, HelloWellness may refund your payment minus a $50 professional services fee, but only if you ask within 24 hours of the provider's review. The identity details sit in the terms rather than on the product cards: HelloWellness LLC and Southend Pharmacy as a fulfillment partner are named there, but the actual dispensing pharmacy, applicable state list, clinician and lab protocol for a selected order remain unconfirmed. Those are useful questions before a growth-hormone-axis peptide.

The sermorelin product charges $349 today for the first three-month plan, then $349 every 11 weeks; its $116 monthly headline is an equivalent, not a monthly purchase. The current NAD⁺ product page charges $297 today and every 11 weeks and says an approved order includes at least three 1,000 mg vials. The homepage still says NAD⁺ starts at $79 a month and its general footnote says $239 every 11 weeks. That conflict prevents treating $79 or $239 as the settled NAD⁺ price. Eleven weeks is shorter than three calendar months, and no stand-alone month-to-month option is shown. The site promises a refund if the provider declines, but its policy says that after completed review and a written prescription, a cancellation may receive payment less a $50 professional fee only if emailed within 24 hours; dispensed medication is nonrefundable. Confirm the selected checkout amount, fees and renewal date before purchase.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. HelloWellness describes its products as compounded by a USA-based 503(a) pharmacy, and its terms name AP Max, Inc. d/b/a Southend Pharmacy as a fulfillment partner, not the dispenser assigned to a selected order. Compounded sterile products are still not FDA-reviewed for purity and potency the way approved drugs are. Its LegitScript seal is worth a specific caution: it links to a verification issued for a different web address from the one you buy on, so confirm the two are the same operating entity before treating the seal as covering the site you are buying from. On the evidence, sermorelin, NAD⁺ and glutathione are not equivalent. Sermorelin acts on the growth-hormone axis — a real, well-described mechanism — but the long-term human outcome data stays thin and no controlled trial demonstrates the performance, recovery or body-composition results the brand's men's-longevity positioning is built on. Injected NAD⁺ has no controlled human outcome trials at all; the single human intravenous study was a pharmacokinetic pilot finding that infused NAD⁺ clears from plasma quickly, and the NAD⁺ forms with human data are the oral precursors NR and NMN, which reliably raise blood NAD⁺ — a raised biomarker rather than a demonstrated clinical benefit. Injectable glutathione has essentially no controlled human outcome evidence. Individual results vary.